Gellan gum appears in products for the two most heavily scrutinised consumer groups in food: infants and patients on medical nutrition. That is worth understanding, because it tells you something about the margin of safety — and because the rules here are more restrictive than anywhere else.
Why formulators use it in these products
Liquid nutritional products have a hard technical problem: they carry minerals, protein, fat and often insoluble ingredients such as calcium salts or fibre, and they must stay homogeneous through months of storage. Sedimentation and creaming are quality defects that consumers notice immediately.
Low acyl gellan gum solves this at very low doses. Because it forms a weak, pourable gel network rather than a thick solution, it keeps particles suspended without increasing viscosity noticeably — essential when the product has to pass through a teat, a straw or a feeding tube.
That combination — suspension at a dosage that a patient barely perceives as thickness — is the reason it appears in these categories at all.
What the safety data says for these groups
The EFSA re-evaluation of E 418 is directly relevant, because the highest-exposure population it identified was toddlers. The refined exposure estimate for toddlers at the 95th percentile was up to 72.4 mg/kg body weight per day — the highest of any group assessed.
Despite that, the panel concluded there was no safety concern at the refined exposure assessment for reported uses and use levels, and no need for a numerical ADI. It also found gellan gum unlikely to be absorbed intact and not fermented by human intestinal microbiota, which is reassuring for infants in particular: a substance that passes through without being metabolised by gut bacteria does not disturb the developing microbiome the way a fermentable fibre might.
The one qualifier to carry forward is the potential laxative effect at high intakes, which regulators have noted applies to this class of ingredient. In practice, use levels in these products are low and the effect appears only at much higher intakes.
The regulatory position is category-specific
This is the part that trips people up. There is no global answer to "is gellan gum permitted in infant or medical nutrition?" The answer is always: in which market, in which product category, at which level?
| Market | How to establish the position |
|---|---|
| European Union | Check Annex II of Regulation (EC) No 1333/2008 for the specific food category, plus purity criteria in Regulation (EU) No 231/2012 |
| United States | Check 21 CFR 172.665 and, for medical foods, the applicable framework |
| China | GB 2760 sets permitted additives by food category; GB 25535 covers the product specification |
| Other markets | National additive lists, often derived from Codex |
Two practical consequences:
- Do not rely on a supplier's general statement such as "approved worldwide". Ask for the specific category.
- Medical nutrition is not one category. Foods for special medical purposes, foods for particular nutritional uses, and standard foods can each be regulated differently within the same country, and the boundaries have shifted over time.
Technical considerations specific to these products
If you are formulating in this space, four things matter more than usual:
- Dosage precision. At the low levels used for suspension, small absolute differences matter proportionally more. Weighing accuracy and premix dilution become quality-critical steps.
- Mineral interactions. These products are mineral-rich by design. The calcium and magnesium present will interact with the gellan gum, and the ionic load is a formulation variable you cannot treat as fixed. Reformulating the mineral premix can change suspension behaviour.
- Heat treatment. Sterilisation and UHT conditions affect hydration and network formation. Process and formulation must be developed together, not sequentially.
- Homogeneity through the fill. In a product that settles during storage, the first and last portions dispensed differ. Suspension must be verified at the top and bottom of the container, at end of shelf life, not only at release.
What to ask a supplier
- Can you confirm the additive is authorised for our specific category in our market, and supply the reference?
- What is the typical dosage range for suspension in high-mineral liquid matrices?
- Which grade — high acyl or low acyl — do you recommend for a product that must remain pourable after sterilisation?
- Can you supply elemental impurity and microbiological data at the level a medical nutrition customer requires?
For technical data and formulation support on gellan gum (E418) in nutritional applications, contact Cinogel.
Part of the E418.org gellan gum knowledge base. Always verify authorisation for your specific food category and market before product development.